BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE). Vaccine 2019;37:2687-93. [PMID: 30975569 DOI: 10.1016/j.vaccine.2019.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yasuda I, Suzuki M, Dhoubhadel BG, Terada M, Satoh A, Sando E, Hiraoka T, Kurihara M, Matsusaka N, Kawahara F, Ariyoshi K, Morimoto K. The low carriage prevalence of pneumococcus among community-dwelling older people: A cross-sectional study in Japan. Vaccine 2020;38:3752-8. [PMID: 32265047 DOI: 10.1016/j.vaccine.2020.03.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Igarashi A, Hirose E, Kobayashi Y, Yonemoto N, Lee B. Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumococcal disease in Japan. Expert Rev Vaccines 2021;:1-13. [PMID: 34259118 DOI: 10.1080/14760584.2021.1952869] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mo Y, Zeng J, Xiao C, Zhang, Wang L, Lu F, Johnson DW, Stålsby Lundborg C, Nitsch D, Liu X, Su G. Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis. Vaccine 2020;38:7422-32. [PMID: 33059969 DOI: 10.1016/j.vaccine.2020.09.080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Danis K, Varon E, Lepoutre A, Janssen C, Forestier E, Epaulard O, N'guyen Y, Labrunie A, Lanotte P, Gravet A, Pelloux I, Chavanet P, Levy-Bruhl D, Ploy MC, Gaillat J; SIIPA Group . Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France. Open Forum Infect Dis 2019;6:ofz510. [PMID: 31868865 DOI: 10.1093/ofid/ofz510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Feldman C, Anderson R. Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000Res 2020;9:F1000 Faculty Rev-338. [PMID: 32411353 DOI: 10.12688/f1000research.22341.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Matsuo A, Takamori A, Kawaura F, Iwanaga Y, Ono H, Kobayashi-Watanabe N, Kuwahara M, Takagi K, Nagasawa Z, Fujimoto K, Hayashi S. Risk for prolonged hospitalization and mortality in aged community acquired pneumonia patients: a retrospective study in Japan. J Clin Biochem Nutr 2020;67:302-6. [PMID: 33293772 DOI: 10.3164/jcbn.20-85] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 de Miguel S, Domenech M, González-camacho F, Sempere J, Vicioso D, Sanz JC, Comas LG, Ardanuy C, Fenoll A, Yuste J. Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era. Clinical Infectious Diseases 2020. [DOI: 10.1093/cid/ciaa1483] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
8 Ishiwada N. Current situation and need for prevention of invasive pneumococcal disease and pneumococcal pneumonia in 6- to 64-year-olds in Japan. J Infect Chemother 2021;27:7-18. [PMID: 33011068 DOI: 10.1016/j.jiac.2020.09.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Khodaei F, Ahsan A, Chamanifard M, Zamiri MJ, Ommati MM. Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor. J Biochem Mol Toxicol 2020;34:e22594. [PMID: 32770858 DOI: 10.1002/jbt.22594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zintgraff J, Fossati S, Pereira CS, Veliz O, Regueira M, Moscoloni MA, Irazu L, Lara C, Napoli D; Argentina Spn Working Group. Distribution of PCV13 and PPSV23 Streptococcus pneumoniae serotypes in Argentinean adults with invasive disease, 2013-2017. Rev Argent Microbiol 2020;52:189-94. [PMID: 31932112 DOI: 10.1016/j.ram.2019.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dhoubhadel BG, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Ishida M, Hamaguchi S, Aoshima M, Yasunami M, Ariyoshi K, Morimoto K; Adult Pneumonia Study Group-Japan (APSG-J). High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors. Thorax 2022:thoraxjnl-2021-217979. [PMID: 35474029 DOI: 10.1136/thoraxjnl-2021-217979] [Reference Citation Analysis]